Leslie Bottoroff leaves Onset Ventures for GE Ventures: report
Longtime Onset Ventures managing director Leslie Bottorff has quietly stepped down from her role.
Bottorff, who spent 15 years with the Menlo Park venture capital firm, will leave to work at GE Ventures as managing director focused on health care companies, GE's director of communications, Leigh Farris, told us.
Fortune first noted that Botorff would leave Onset Ventures, which has eight funds and has backed more than 130 startups since 1984, according to its website. GE Ventures, which has a San… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 14, 2014 Category: American Health Authors: Sarah Drake Source Type: research
Clarus Ventures seeks $375 million for third life sciences fund
Clarus Ventures, which has backed some big Bay Area biotech M&A winners over the past year, is raising $375 million for a third fund, part of a $2 billion or more surge in life sciences VC funds over the past year.
The venture capital firm, with offices in South San Francisco and Cambridge, Mass., disclosed its third fund in a Securities and Exchange Commission filing Thursday.
The target for the fund is less than its two previous funds of $500 million in 2005 and $660 million in 2008, Fierce Biotech… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - February 7, 2014 Category: Hospital Management Authors: Ron Leuty Source Type: research
US biomedical R&D spending declines, Asian spending soars
Nature Reviews Drug Discovery 13, 91 (2014).
doi:10.1038/nrd4244
Shifts in industry, rather than public, investments are driving changes in the regional biomedical R&D landscape.The lowdown: Justin Chakma, a venture capital investor at Thomas, McNerney & Partners in La Jolla, California, and his colleagues obtained data on biomedical research and development (R&D) (Source: Nature Reviews Drug Discovery)
Source: Nature Reviews Drug Discovery - January 31, 2014 Category: Drugs & Pharmacology Tags: News and Analysis Source Type: research
Quantum Health lands funding from team led by GE Ventures, Altaris Capital
GE Ventures and a coalition of health-care investment veterans have taken a minority stake – but an active role in landing new customers – in Quantum Health Inc.
“This team definitely brings assets we previously didn’t have,” Quantum CEO Kara Trott said.
The Columbus-based health-care coordination firm announced the deal for an undisclosed sum Wednesday with three groups: The venture capital arm of General Electric Co. (NYSE:GE); Altaris Capital Partners LLC, a New York City firm investing… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 22, 2014 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: research
The big issue facing medical device startups (hint: it’s not VC)
The big holdup in starting a new medical device company isn’t a slowdown in venture capital, though that is happening, or a slow regulatory process, though that, too, is happening.
The main obstacle is a lack of medical codes.
Ashley Wallin, executive director and vice president for AdvaMed’s Emerging Growth Company Council, said one of the biggest issues facing startup medical device companies is reimbursements from insurance firms to device manufacturers, which complicate the process of valuing… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 21, 2014 Category: Biotechnology Authors: Dan Mayfield Source Type: research
Relatient completes first round of VC funding
Relatient, a Franklin-based health care software and services company, has finished its first round of venture capital financing, according to a news release.
The company did not disclose the amount of financing, which was led by former AIM Healthcare President Jim Sohr. Joe Storey, a former executive vice president at WebMedx, also participated in the raise, along with a third undisclosed investor.
According to the release, the company will use the new funding to expand its sales force, accelerate… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 21, 2014 Category: Biotechnology Authors: Eleanor Kennedy Source Type: research
Info session spells out Start-UpNY details
The Start-Up NY program is a central element in New York state’s efforts to create a statewide system of support and services for entrepreneurs, connecting young companies to investors and linking New York City’s high-powered economy to beleaguered counterparts in Upstate and Western New York.
That includes Innovation Hot Spots across the state, including the one anchored by the University at Buffalo and other local partners, with the state-run venture capital funds aimed at tech and life sciences… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 17, 2014 Category: American Health Authors: Dan Miner Source Type: research
Best quarter since 2008 boosts VC take to $269M
Minnesota companies closed out 2013 with $269 million in venture capital on hand, thanks partly to a strong fourth quarter.
VCs invested nearly $117 million in the state’s startups during the final three months of the year. That’s the largest quarterly haul reported since 2008, according to the MoneyTree Report, which is compiled by PricewaterhouseCoopers and the National Venture Capital Association using data from Thomson Reuters.
Minnesota’s total for the year was up moderately compared… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 17, 2014 Category: American Health Authors: Katharine Grayson Source Type: research
Baltimore, D.C. venture capital investment reaches 12-year high
Venture capitalists more than doubled their investment in companies based Baltimore- and Washington, D.C.-area companies in 2013.
Venture firms invested more than $1.5 billion in the region in 2013, making that the biggest year for investment since 2001, according to the latest MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association. Maryland companies took in 43 percent of that investment money.
Nationally, venture capital firms invested $29.4 billion in 2013,… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - January 17, 2014 Category: Hospital Management Authors: Sarah Gantz Source Type: research
The view beyond venture capital
Nature Biotechnology 32, 15 (2014).
doi:10.1038/nbt.2780
Authors: Dennis Ford & Barbara Nelsen
Fundraising is an integral part of almost every young biotech's business strategy, yet many entrepreneurs do not have a systematic approach for identifying and prioritizing potential investors—many of whom work outside of traditional venture capital. (Source: Nature Biotechnology)
Source: Nature Biotechnology - January 9, 2014 Category: Biotechnology Authors: Dennis FordBarbara Nelsen Tags: Bioentrepreneur Source Type: research
Cambia leads $5M funding round in virtual personal trainer startup
It’s Jan. 2 and many people have surely resolved to lose weigh and work out more in 2014. Sadly and predictably for many of us, in just a matter of weeks, those resolutions will be forgotten.
Portland-based Cambia Health Solutions Inc. has invested in a personalized fitness tool to help you keep those resolutions. Cambia led a $5 million venture capital round in Retrofit, a 2-year-old startup that offers consumers a virtual personal trainer, nutritionist and psychologist.
“It’s like having… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 2, 2014 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: research
Respira reels in VC funding, relocates to BioScience Center
The BioScicence Center has recruited the company Respira Therapeutics as its newest tenant.
Respira also announced Wednesday that it has closed on a venture capital deal from Sun Mountain Capital and Cottonwood Technology Fund for development. Terms of the deal were not disclosed. Respira was founded in 2010 and is designing a new inhaler that could help with respiratory diseases and other diseases.
“Respira is very pleased to welcome Sun Mountain as a new investor and for the continuing support… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 18, 2013 Category: Pharmaceuticals Authors: Dan Mayfield Source Type: research
VC and non-profit unite to launch new companies
Nature Reviews Drug Discovery 12, 895 (2013).
doi:10.1038/nrd4195
Puretech Ventures has teamed up with non-profit JDRF in bid to launch a new model of company creation.The lowdown: Venture capital (VC) biotech funding has flagged since 2007, forcing entrepreneurs to find other backers to bankroll their projects. Puretech Ventures' Valley of Life (Source: Nature Reviews Drug Discovery)
Source: Nature Reviews Drug Discovery - November 29, 2013 Category: Drugs & Pharmacology Tags: News and Analysis Source Type: research
Fanatics Inc.'s $170M VC deal sixth biggest in U.S.
Fanatics Inc.’s $170 million funding was the sixth biggest venture capital deal in the U.S. this year, reports sister pub The Silicon Valley Business Journal.
The Jacksonville-based online retailer pushed its valuation to $3.1 billion following the June raise, double its 2012 value.
The retailer is expecting $1 billion in revenue this year, Michael Rubin, CEO of Fanatic’s parent company Kynetic LLC, told the Wall Street Journal in June. Fanatics CEO Alan Trager’s backers include Temasek Holdings,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 25, 2013 Category: American Health Authors: Ashley Gurbal Kritzer Source Type: research
